The Patent - Invention Magazine
en

Patents

Norms & Regulation

Australian Federal Court Clears Samsung Bioepis in Pfizer Enbrel Patent Dispute

The Federal Court of Australia has ruled that manufacturing processes for biosimilar Brenzys products do not infringe a Pfizer process patent. The decision in Pfizer Ireland Pharmaceuticals Unlimited Company v Samsung Bioepis Co., Ltd resolves claims over the production methods for the etanercept therapy Enbrel. The ruling provides clarity on the scope of intellectual property rights governing biosimilar manufacturing.

Norms & Regulation

Federal Circuit overturns 9.1 million dollar fee award against ChromaDex

The U.S. Court of Appeals for the Federal Circuit has overturned a 9.1 million dollar legal fee award against ChromaDex in its long-running dispute with Elysium Health. The appellate court ruled that ChromaDex presented a plausible defense of its patent eligibility under Section 101, meaning the case did not qualify as exceptional under federal patent law.

Archeology

Study Maps Age Gap in African American Elder Care Views

A study led by the University of Rhode Island has evaluated generational attitudes toward elder care among African Americans, highlighting clear differences between age groups. The research, published in Sociological Focus, assesses whether family members, government systems, or shared models should manage elder care. The findings provide demographic insight to help shape public health strategies and caregiving support frameworks.

Giovanni Sapere

Patents

Patent System Under Scrutiny, IP Education Lags in MBA Programs

A persistent public relations campaign is actively undermining confidence in the patent system, often labeling legitimate protections as “bad patents” or their owners as “trolls” to excuse infringement [IPWatchdog - Bad Patents]. Concurrently, a new report highlights a critical gap in business education: none of the top 20 U.S. MBA programs require a course on intellectual property, despite its increasing economic importance [IPWatchdog - Intangible Investor]. These trends pose challenges to the foundational framework that supports innovation.

Letizia Giugliano

Patents

Cross-Border AI Verification Seeks Trade Secret Protection

As artificial intelligence (AI) systems are licensed across international borders, developers face the challenge of proving compliance with regulations while safeguarding their proprietary technology. A proposed framework, the International AI Assurance and Access Compact, seeks to address this by offering a structured approach to cross-border verification without compromising trade secrets [IPWatchdog](https://ipwatchdog.com/2026/10/08/ai-verification-and-trade-secrets-a-cross-border-framework/). This initiative aims to streamline the process for U.S. AI developers and others operating globally, ensuring both oversight and protection for valuable intellectual property.

Giovanni Sapere

News

Creativity pays off: patents generate 7 million jobs in Italy

A study by the EPO and EUIPO shows that, in Italy, companies with a high patent density (IPR) employ 1 in 3 people. Italy: home of saints, poets and inventors. The numbers say it: in our country, companies that make intensive use of trademarks and patents generate 50% of the national GDP and employ…

Giovanni Sapere

Events

The creators present at our event: Milano Digital Week presents Makerstarts

Our guests at Digital Week, the event dedicated to innovations in which we presented our ambitious project “Makerstarts” We carefully selected each of our guests to preview Makerstarts Expo, the event specially created in collaboration With theAssociation Of InnovaMarketing professionals. In Milan,…

Giovanni Sapere